Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox Pretreatment for Lip Repositioning in Gummy Smile
NCT04030767Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Sep 2019
- Primary completion
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 1, randomised, single-blind trial of botulinum toxin type A in excessive gingival display (2 arms), sponsored by Cairo University. Primary endpoint: Change in amount of gingival display at 1 year. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
excessive gingival display
Beyond the preview
Go deeper on NCT04030767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04030767.